IQVIA Biotech

IQVIA Biotech is a division of IQVIA Holdings ., specializing in clinical research services for emerging and mid-sized biopharmaceutical companies. Headquartered in Durham, North Carolina, it provides contract research, data analytics, and regulatory support for drug development. IQVIA Holdings reported approximately $15 billion in revenue in 2023, with IQVIA Biotech contributing significantly to its R&D service segment. The company relies on technology vendors, data-management platforms, and laboratory partners to deliver integrated research solutions. Its governance model ludes vendor qualification, GxP compliance, and cybersecurity oversight for sensitive clinical and patient data. IQVIA Biotech’s digital systems employ machine learning and cloud-based analytics to improve trial efficiency and transparency, aligning with evolving FDA and EMA regulatory expectations.

IQVIA Biotech Overview

  • Company: IQVIA Biotech
  • Industry: Construction & Engineering
  • Employees: 10,001+
  • Location: Durham, NC, USA
  • Founded: 1982

IQVIA Biotech Certifications and Compliance

Through Panorays' Attack Surface Assessments, you can view all identified published certifications, providing a clearer and more accurate understanding of your compliance status

IQVIA Biotech Cyber Related News

Access business-specific cyber news from diverse sources, all categorized and consolidated in one place, ensuring clear visibility into cyber events and incidents relevant to your organization.
#0
No relevant cyber news available at this time.

IQVIA Biotech External Attack Surface Geolocation Map

Gain detailed insights into the location of your assets through our comprehensive external assessments.

IQVIA Biotech Supply Chain Discovery

Supply Chain Discovery identifies Nth-party connections to your company, maps their relationships, and continuously monitors them for cyber threats. The following graph segments detected third parties according to their Cyber Posture Rating.

IQVIA Biotech Cyber Posture Rating

IQVIA Biotech security rating reflects the analysis of its external attack surface. A higher rating indicates a stronger security posture. Begin a free trial to receive a comprehensive risk assessment for IQVIA Biotech.
Is this your company? Claim your security score now.
NA

IQVIA Biotech Category Breakdown

Human

Employee NA
Security Team NA
Social Posture NA
Dynamics NA

Application

Techs NA
Application Security NA
Domain Attacks NA
Exposed Services NA

IT

DNS NA
Mail Server NA
Asset Reputation NA
Web Server NA
TLS NA
Cloud NA
Endpoint NA
Forrester logo

Panorays is a Leader

“Panorays stands out with one of the most ambitious roadmaps and innovation driven approaches to agentic AI in this evaluation…”

Get the Report

Panorays is a Leader - in The Forrester Wave in Cybersecurity Risk Ratings Platforms, 2026

Is your organization secure?

Discover critical risks and vulnerabilities in your supply chain with our comprehensive report.